Overexpression of Ubiquilin4 is associated with poor prognosis in patients with cervical cancer

Table 1 Relationship between Ubiquilin4 protein expression and clinicopathological features in 117 cases of cervical cancer

Variables		UBQLN4 expression		Total	Χ2	P value
		Low	High
Age (yr)					0.713	0.398
	≤ 45	34	24 (41.4%)	58
	> 45	30	29 (49.2%)	59
	Null
Pathologic type					0.244	0.885
	AD	2	1 (33.3%)	3
	ASC	3	2 (40.0%)	5
	SCC	59	50 (45.9%)	109
Lymph node metastasis					0.242	0.623
	No	53	42 (44.2%)	95
	Yes	11	11 (50.0%)	22
Histological grade					1.518	0.279
	I/II	16	12 (42.9%)	28
	III	39	50 (56.2%)	89
FIGO stage (2018)					0.242	0.623
	I/II	53	42 (44.2%)	95
	III	11	11 (50.0%)	22

AD: Adenocarcinoma; ASC: Adenosquamous carcinoma; SCC: Squamous cell carcinoma.